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Acute sinusitis and sore throat in 
primary care
SUMMARY
Sore throat and acute sinusitis are not straightforward diagnoses. Trying to guess the responsible 
pathogen may not be the best approach.
Being guided by empirical evidence may be more useful. It suggests some, but very few, benefits 
for antibiotics. This has to be balanced with some, but few, harms from antibiotics, including 
diarrhoea, rash and thrush.
Prescribers should also be aware of the risk of antibiotic resistance for the individual, as well as for 
the population as a whole.
GPs should explain the evidence for the benefits and the harms of antibiotics to patients within a 
shared decision-making framework.
such as acute otitis media, sinusitis and quinsy. It 
is notoriously hard to predict from clinical signs,1 
and culturing takes days, leaving only near-patient 
antigen testing as an option. Moreover, group A 
beta-haemolytic streptococci together with other 
organisms that cause respiratory infections (Neisseria 
meningitidis, Haemophilus, Chlamydia and Legionella) 
exist very commonly in people without symptoms.
Before focusing too closely on diagnosis, it is worth 
thinking about its purpose. How will treatment be 
influenced by diagnosis?
Treatment
The natural course of both sore throat and sinusitis 
is spontaneous resolution. Three questions should 
be asked:
 • Do antibiotics reduce the severity or duration 
of symptoms?
 • Do they reduce any complications?
 • Do other interventions relieve symptoms?
These are necessary questions because of the 
spectre of antibiotic resistance – something that is 
approaching a catastrophe.2
The evidence: antibiotics for acute sinusitis
In a Cochrane review investigating antibiotics for 
acute sinusitis, five studies randomised over 1000 
patients to antibiotics or placebo.3 Analysis of 
the trials found there was a 0.66 risk ratio 
(95% CI* 0.47–0.94) if antibiotics were used, which 
* CI confidence interval
Introduction
Sore throat and acute sinusitis are both common 
reasons for consultations in Australian primary care. 
However, deciding how to manage affected patients is 
far from straightforward.
Diagnosis
Acute respiratory infections involve the respiratory 
mucosa that lines the pharynx and nasal passages, 
including sinuses and upper airway. Accurate 
diagnosis is clouded by a very wide spectrum 
of different sources of illness, and a vast array 
of microorganisms that are associated with, and 
may cause, infection. Many of these bacteria are 
normally present as commensals. We probably shed 
different types of virus far more often than we suffer 
symptoms of a viral infection.
Symptoms can start at any mucosal site and go to any 
other – sniffles (nose), sore throat (tonsils or pharynx), 
acute cough (upper airway) and fever or malaise 
(systemic) – in any order (see Fig.).
Is the infection bacterial or viral?
Because the question of whether an infection is caused 
by bacteria or a virus underpins the conventional 
rational approach to management of infections, it has 
been the focus of much investigation. However, many 
studies of the microbiological environment of people 
with infection are difficult to interpret.
One of the organisms of greatest concern is 
group A beta-haemolytic streptococci. Historically, 
this infection has resulted in non-suppurative 
complications (acute rheumatic fever and 
glomerulonephritis), and secondary infections 
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one of them to benefit is 3.7 for those who have a 
positive throat swab for streptococci, 6.5 for those 
with a negative swab, and 14.4 for those not swabbed. 
It should be noted that trials that did not swab had a 
less serious case mix.
So if symptom control is not a good enough reason 
for using antibiotics, are there other reasons? 
Historically, sore throat has been of greater concern 
for its complications than its symptoms. Of these, 
acute rheumatic fever dominates. It is hard for us 
to appreciate now, 100 years later, the fear of ‘strep 
throat’ that used to frighten parents. An analysis 
of 16 trials of 10 101 patients found that 10 days 
of penicillin for sore throat was highly protective 
against acute rheumatic fever, with a risk ratio of 
0.20 (95% CI 0.18–0.44).4 However, the trials are now 
more than 50 years old, and acute rheumatic fever 
has been disappearing steadily since the start of the 
1900s. (The discovery of antibiotics in the mid-1900s 
makes no discernible blip on this downward trend.) 
Now the risk of acute rheumatic fever is low – one 
case in every 10 GP-practising lifetimes – and is a 
weak justification for antibiotic use. In contrast, rural 
and remote indigenous communities of Australia 
experience acute rheumatic fever enough for 
antibiotic use for sore throat to be important.
Harms from antibiotics
Evidence is accumulating that antibiotics deliver 
common harms, including rashes, diarrhoea and 
thrush. However, data on adverse drug reactions are 
not comprehensive.5 If the infection is serious, these 
means the relative risk of still having the illness at 
1–2 weeks was 66% with antibiotics. Nevertheless, 
86% of patients given placebo had recovered by 
1–2 weeks anyway. This means that six out of every 
seven patients treated with antibiotics gained no 
benefit after 1–2 weeks, and by 16 to 60 days there 
was no difference in recovery and reports of 
complications between the antibiotic and placebo 
groups. The diagnostic inclusion criteria for the trials 
were rigorous with confirmation by X-ray or CT scan, 
or sinus puncture and aspiration. Clinical diagnosis 
was also more stringent than in normal clinical 
practice in Australia. The normal diagnostic spectrum 
of disease is much wider in general practice than in 
the trials, so the response to treatment would 
probably be less.
The evidence: antibiotics for acute 
sore throat
Another Cochrane review identified 15 trials (including 
3621 participants) assessing antibiotics for acute 
sore throat.4 These trials reported on the incidence 
of symptoms three days after the patient had been 
seen by a clinician. (This is when the greatest benefit 
of antibiotics is evident.) In the control group, about 
77% of patients were still experiencing throat soreness 
compared with 66% of patients given antibiotics 
(mostly penicillin). This represents a risk ratio of 
0.68 (95% CI 0.59–0.79). The evidence is very robust 
(even a new well-conducted trial is unlikely to alter 
the summary effect substantively).4 The number of 
patients who need to be treated with antibiotics for 
Fig.    Overlapping symptoms and diagnoses of different acute respiratory infections
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Bringing this all together when 
talking to patients
The great challenge is communicating this complexity 
to patients, who might oversimplify the problem to 
the fact that there is infection, that it may be caused 
by bacteria and that antibiotics kill bacteria. A shared 
decision-making approach enables the clinician to 
explain the evidence to the patient clearly so they 
can join in when the health choices are made.8 
When presented with evidence, patients are often 
surprised to find the benefits modest, with harms of 
the same effect size, and become less interested in 
pursuing antibiotics.
Conclusion
Treatment options for sore throat and acute sinusitis 
are few. However, the illnesses resolve without 
treatment and, with a few important exceptions, 
complications are rarely a problem. We probably 
do patients most good by excluding more sinister 
illness, and reassuring them that the illness will 
spontaneously resolve. 
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common adverse reactions can be dismissed as 
trivial. However, if as in the case of antibiotics for sore 
throat and acute sinusitis, the benefits are marginal, 
antibiotic harms need to be factored in. GPs should 
discuss these harms, balanced against any benefits, 
with the patient before deciding on management.
Antibiotic resistance
There is also concern about antibiotic resistance. This 
is obvious for harm at the population level, but there 
is evidence that individuals carry antibiotic-resistant 
commensal bacteria for up to 12 months.6 The extent 
to which this compromises the effectiveness of 
antibiotics for subsequent potentially more serious 
infections has not been quantified.
Alternatives to antibiotics
Currently there are few effective alternatives to 
antibiotics in primary care. There is surprisingly 
little empirical evidence for the effectiveness of 
analgesics, and too little for other over-the-counter 
products (decongestants, several complementary 
and alternative medicines, caffeine) to recommend 
them. Steroids have been shown to be effective for 
acute sinusitis in four trials of 1943 patients.7 After 
2–3 weeks, sinusitis resolved or improved in 73% of 
patients using intranasal steroids compared with 66% 
of those not using them, which means that 14 patients 
need to be treated for one to benefit.
Antibiotic. Version 15. In: eTG complete [Internet]. Melbourne: 
Therapeutic Guidelines Limited; 2016. www.tg.org.au [cited 
2016 Jul 1]
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